McKesson Income from Continuous Operations 2010-2024 | MCK
McKesson annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- McKesson income from continuous operations for the quarter ending September 30, 2024 was $0.287B, a 59.17% decline year-over-year.
- McKesson income from continuous operations for the twelve months ending September 30, 2024 was $2.707B, a 25.73% decline year-over-year.
- McKesson annual income from continuous operations for 2024 was $3.16B, a 15.17% decline from 2023.
- McKesson annual income from continuous operations for 2023 was $3.725B, a 188.31% increase from 2022.
- McKesson annual income from continuous operations for 2022 was $1.292B, a 129.78% decline from 2021.
McKesson Annual Income from Continuous Operations
(Millions of US $) |
| 2024 |
$3,160 |
| 2023 |
$3,725 |
| 2022 |
$1,292 |
| 2021 |
$-4,339 |
| 2020 |
$1,126 |
| 2019 |
$254 |
| 2018 |
$292 |
| 2017 |
$5,277 |
| 2016 |
$2,342 |
| 2015 |
$1,842 |
| 2014 |
$1,414 |
| 2013 |
$1,363 |
| 2012 |
$1,379 |
| 2011 |
$1,130 |
| 2010 |
$1,263 |
| 2009 |
$823 |
McKesson Quarterly Income from Continuous Operations
(Millions of US $) |
| 2024-09-30 |
$287 |
| 2024-06-30 |
$960 |
| 2024-03-31 |
$830 |
| 2023-12-31 |
$630 |
| 2023-09-30 |
$703 |
| 2023-06-30 |
$997 |
| 2023-03-31 |
$826 |
| 2022-12-31 |
$1,119 |
| 2022-09-30 |
$973 |
| 2022-06-30 |
$807 |
| 2022-03-31 |
$407 |
| 2021-12-31 |
$39 |
| 2021-09-30 |
$310 |
| 2021-06-30 |
$536 |
| 2021-03-31 |
$713 |
| 2020-12-31 |
$-6,174 |
| 2020-09-30 |
$627 |
| 2020-06-30 |
$495 |
| 2020-03-31 |
$1,072 |
| 2019-12-31 |
$247 |
| 2019-09-30 |
$-676 |
| 2019-06-30 |
$483 |
| 2019-03-31 |
$-744 |
| 2018-12-31 |
$527 |
| 2018-09-30 |
$552 |
| 2018-06-30 |
$-81 |
| 2018-03-31 |
$-1,087 |
| 2017-12-31 |
$960 |
| 2017-09-30 |
$56 |
| 2017-06-30 |
$363 |
| 2017-03-31 |
$3,630 |
| 2016-12-31 |
$649 |
| 2016-09-30 |
$325 |
| 2016-06-30 |
$673 |
| 2016-03-31 |
$465 |
| 2015-12-31 |
$642 |
| 2015-09-30 |
$636 |
| 2015-06-30 |
$599 |
| 2015-03-31 |
$411 |
| 2014-12-31 |
$521 |
| 2014-09-30 |
$491 |
| 2014-06-30 |
$419 |
| 2014-03-31 |
$399 |
| 2013-12-31 |
$164 |
| 2013-09-30 |
$423 |
| 2013-06-30 |
$428 |
| 2013-03-31 |
$279 |
| 2012-12-31 |
$306 |
| 2012-09-30 |
$399 |
| 2012-06-30 |
$379 |
| 2012-03-31 |
$497 |
| 2011-12-31 |
$300 |
| 2011-09-30 |
$296 |
| 2011-06-30 |
$286 |
| 2011-03-31 |
$422 |
| 2010-12-31 |
$155 |
| 2010-09-30 |
$255 |
| 2010-06-30 |
$298 |
| 2010-03-31 |
$348 |
| 2009-12-31 |
$326 |
| 2009-09-30 |
$301 |
| 2009-06-30 |
$288 |
| 2009-03-31 |
$281 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$78.151B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
